These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 38195680)

  • 1. Carrier systems of radiopharmaceuticals and the application in cancer therapy.
    Zhang T; Lei H; Chen X; Dou Z; Yu B; Su W; Wang W; Jin X; Katsube T; Wang B; Zhang H; Li Q; Di C
    Cell Death Discov; 2024 Jan; 10(1):16. PubMed ID: 38195680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer.
    Alati S; Singh R; Pomper MG; Rowe SP; Banerjee SR
    Semin Nucl Med; 2023 Sep; 53(5):663-686. PubMed ID: 37468417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapy in nuclear medicine--current status and future prospects.
    Oyen WJ; Bodei L; Giammarile F; Maecke HR; Tennvall J; Luster M; Brans B
    Ann Oncol; 2007 Nov; 18(11):1782-92. PubMed ID: 17434893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radionuclide therapy of cancer with radiolabeled antibodies.
    Boerman OC; Koppe MJ; Postema EJ; Corstens FH; Oyen WJ
    Anticancer Agents Med Chem; 2007 May; 7(3):335-43. PubMed ID: 17504159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic radiopharmaceuticals.
    Ercan MT; Caglar M
    Curr Pharm Des; 2000 Jul; 6(11):1085-121. PubMed ID: 10903384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological carrier molecules of radiopharmaceuticals for molecular cancer imaging and targeted cancer therapy.
    Aerts A; Impens NR; Gijs M; D'Huyvetter M; Vanmarcke H; Ponsard B; Lahoutte T; Luxen A; Baatout S
    Curr Pharm Des; 2014; 20(32):5218-44. PubMed ID: 24606796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Frontiers in Molecular Imaging Using Peptide-Based Radiopharmaceuticals for Prostate Cancer.
    Li X; Cai H; Wu X; Li L; Wu H; Tian R
    Front Chem; 2020; 8():583309. PubMed ID: 33335885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide motifs for insertion of radiolabeled biomolecules into cells and routing to the nucleus for cancer imaging or radiotherapeutic applications.
    Costantini DL; Hu M; Reilly RM
    Cancer Biother Radiopharm; 2008 Feb; 23(1):3-24. PubMed ID: 18298325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with Radiopharmaceuticals and Radionuclides in Breast Cancer: Current Options.
    Altıparmak Güleç B; Yurt F
    Eur J Breast Health; 2021 Jul; 17(3):214-219. PubMed ID: 34263148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiolabeled peptides in diagnosis and therapy.
    Weiner RE; Thakur ML
    Semin Nucl Med; 2001 Oct; 31(4):296-311. PubMed ID: 11710772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-based Radiopharmaceuticals as Theranostic Agents: An Overview.
    Sharma R; Suman SK; Mukherjee A
    Curr Med Chem; 2022; 29(38):5979-6005. PubMed ID: 35674298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer.
    Giovacchini G; Giovannini E; Riondato M; Ciarmiello A
    Curr Radiopharm; 2017; 10(1):6-15. PubMed ID: 28034291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeled Peptides for SPECT and PET Imaging in the Detection of Breast Cancer: Preclinical and Clinical Perspectives.
    Fu H; Du B; Chen Z; Li Y
    Curr Med Chem; 2020; 27(41):6987-7002. PubMed ID: 32003658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer.
    Okarvi SM
    Cancer Treat Rev; 2008 Feb; 34(1):13-26. PubMed ID: 17870245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor imaging and therapy using radiolabeled somatostatin analogues.
    de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
    Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
    Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
    J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic applications of radiolabeled peptides in nuclear endocrinology.
    Behr TM; Béhé M; Becker W
    Q J Nucl Med; 1999 Sep; 43(3):268-80. PubMed ID: 10568142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of radiolabeled peptides in tumor imaging and therapy.
    Mohtavinejad N; Shafiee Ardestani M; Khalaj A; Pormohammad A; Najafi R; Bitarafan-Rajabi A; Hajiramezanali M; Amanlou M
    Life Sci; 2020 Oct; 258():118206. PubMed ID: 32758623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC1-Targeted Radiopharmaceuticals in Cancer Imaging and Therapy.
    Maleki F; Rezazadeh F; Varmira K
    Mol Pharm; 2021 May; 18(5):1842-1861. PubMed ID: 33821638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-Based Radiopharmaceuticals for Molecular Imaging of Prostate Cancer.
    Stott Reynolds TJ; Smith CJ; Lewis MR
    Adv Exp Med Biol; 2018; 1096():135-158. PubMed ID: 30324352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.